Leif W Ellisen

发表

REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species.

A. Yang, C. Johannessen, D. Haber, 2002, Molecular cell.

A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and 77 78 79 80 81 82 Ovarian Cancer Genes in More Than 1000 Patients

Yuya Kobayashi, James M Ford, Stephen E Lincoln, 2015 .

Induction of GADD45 and JNK/SAPK-Dependent Apoptosis following Inducible Expression of BRCA1

F. Christians, D. Haber, S. Maheswaran, 1999, Cell.

Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.

Chee-Onn Leong, C. Johannessen, L. Ellisen, 2006, Cancer research.

Dexamethasone Represses Signaling through the Mammalian Target of Rapamycin in Muscle Cells by Enhancing Expression of REDD1*

L. Ellisen, S. Kimball, L. Jefferson, 2006, Journal of Biological Chemistry.

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

David N Louis, Ultan McDermott, Jeffrey W. Clark, 2010, EMBO molecular medicine.

The integrin alpha(v)beta(3-5) ligand MFG-E8 is a p63/p73 target gene in triple-negative breast cancers but exhibits suppressive functions in ER(+) and erbB2(+) breast cancers.

Emmett V Schmidt, Tetsu Hayashida, D. Sgroi, 2011, Cancer research.

Bioprinting the Cancer Microenvironment.

Ali Khademhosseini, Yu Shrike Zhang, Rahmi Oklu, 2016, ACS biomaterials science & engineering.

PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition.

Lei He, Violeta Serra, Maurizio Scaltriti, 2012, Cancer discovery.

The molecular pathogenesis of head and neck squamous cell carcinoma.

L. Ellisen, S. Rothenberg, Leif W Ellisen, 2012, The Journal of clinical investigation.

ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis.

Sridhar Ramaswamy, Hongmei Mou, Jayaraj Rajagopal, 2017, Cancer cell.

Standardized decision support in next generation sequencing reports of somatic cancer variants

Rodrigo Dienstmann, Fei Dong, Long P Le, 2014, Molecular oncology.

Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq

Franziska Michor, Simona Cristea, Shawn M. Gillespie, 2018, Nature Communications.

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.

Yuya Kobayashi, James M Ford, Stephen E Lincoln, 2015, JAMA oncology.

p63 and p73: Life and Death in Squamous Cell Carcinoma

L. Ellisen, J. Rocco, James W Rocco, 2006, Cell cycle.